The Metacognitive therapy institute (MCT-I) is an international mental health company founded by leading experts in the field of metacognitive therapy (MCT) and cognitive therapy (CBT). The company’s director and head office is based in Manchester, UK.The other branch is established in Trondheim, Norway.
The main purpose of the company is to develop and disseminate effective psychological treatments to people suffering from psychological disorders. We also develop and provide resources for mental health workers and therapists and offer training workshops to develop high competency skills as protocol therapists in MCT and CBT. We aim to develop a network of MCT-I certified clinicians who are competent MCT practitioners and able to deliver effective treatment to patients with anxiety disorders, trauma, depression and personality disorders. MCT is a regulated therapy and should only be delivered by an MCT-I registered therapists. See our registered therapists page to find an MCT-I registered therapist near you.
The MCT-institute works in accordance with the guidelines and ethical codes of the health authorities in the UK and EU in research and treatment. Only cognitive oriented treatments that are evidence-based for the various mental health disorders are supervised and disseminated.
by Adrian Wells
Attention Training Technique (ATT) is a specific treatment technique developed by Wells (1990) for use in metacognitive therapy. Whilst this technique was originally developed to be a component of treatment, experimental studies have suggested that it can in some instances have significant beneficial effects on anxiety and depression when practiced in its own right. However, we recommend that ATT is used in the context of a full metacognitive therapy treatment package for optimal effects.
The most reliable and objective way of determining the nature and cause of symptoms is through a complete diagnostic assessment. The first visit should be to the family doctor. There are many medical conditions that can give rise to depression, anxiety-like or other psychological symptoms and it is important to rule-out medical or biological causes before exploring a psychological explanation. Some medical conditions require urgent specialist treatment.
Schweiger et al (2019) evaluates the barriers to innovation and development of therapeutic methods from evidenced based techniques. The paper highlights how Metacognitive therapies differs from other psychological therapies by evaluating its development from basic science to psychological interventions. As such, the development of Metacognitive
Preliminary studies highlight that MCT is an effective treatment for PTSD in adults, however less is known on the acceptability, feasibility and efficacy of MCT for PTSD in youth. Simons and Kursawe (2019) evaluated MCT for children and adolescents with PTSD. 21 children and adolescents
MCT has shown to be an effective treatment for Generalized Anxiety Disorder (GAD) in an individual format, however less is known about the effectiveness of group-MCT. Haset et al (2019) evaluated the feasibility of group MCT as well as provides preliminary results on the effectiveness
